Prostate volume variation during 1.5T MR-guided adaptive stereotactic body radiotherapy (SBRT) and correlation with treatment toxicity

医学 前列腺癌 前列腺 核医学 泌尿科 放射治疗 前瞻性队列研究 毒性 放射科 外科 内科学 癌症
作者
Luca Nicosia,P. Ravelli,Michele Rigo,Niccolò Giaj‐Levra,Rosario Mazzola,Edoardo Pastorello,Francesco Ricchetti,Andrea Gaetano Allegra,Ruggero Ruggieri,Filippo Alongi
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
卷期号:190: 110043-110043 被引量:15
标识
DOI:10.1016/j.radonc.2023.110043
摘要

Introduction To evaluate prostate volume change during daily-adaptive prostate SBRT on 1.5 T MR-linac and to correlate it with treatment toxicity. Methods a series of patients affected by low-to-intermediate risk prostate cancer was treated by 5-fraction SBRT within a prospective study (Prot. n° 23748). Total dose was 35 Gy and 36.25 Gy delivered every day or on alternate days. Treatment toxicity was recorded with the following patient reported outcomes (PROMs): IPSS, ICIQ-SF, and EPIC-26. Results 254 patients were included in the analysis. Baseline median CTV volume was 55 cc (range 15.3–163.3). Mean prostate volume were 58.9 cc, and 62.7 cc at first and last fraction respectively (mean volume increase 6.4 %; p = <0.0001). We observed prostate swelling (mean 15.4 % increase) in 50 % of cases, stable volume (≤5% volume change) in 39 % of patients, and prostate shrinkage in 11 % of cases (mean 12.2 % reduction). Baseline CTV > 55 cc showed a trend towards higher CTV shrinkage (-10.5 % versus −14.5 %; p = 0.052). We found no correlation between CTV change and PROMs. Prostate swelling was generally compensated by the planned PTV expansion, even though the mean setup volume dropped from 47.4 cc to 38.9 cc at last fraction, with few cases not covered by initial setup margins. Conclusion The present study reported a significant prostate volume change during prostate SBRT on 1.5T MR-linac. We observed both prostate swelling in half of cases and few cases of prostate shrinkage. No correlations were found with PROMs in this population treatment with daily-adaptive strategy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
所所的应助被迷人的周老师采纳,获得10
1秒前
1秒前
饿得咕咕地完成签到,获得积分10
1秒前
allen完成签到,获得积分10
1秒前
1秒前
1秒前
syvshc的应助被2499297293采纳,获得10
1秒前
Ava的应助被2499297293采纳,获得10
1秒前
赖烊烊完成签到,获得积分10
2秒前
今明源之昨后完成签到,获得积分10
2秒前
思源的应助被疯狂的雨南采纳,获得10
2秒前
研友_VZG7GZ的应助被luoll采纳,获得10
2秒前
shuailee完成签到,获得积分10
2秒前
思源的应助被vvvv采纳,获得20
2秒前
yushengdengsiba完成签到,获得积分10
3秒前
单纯的静竹完成签到,获得积分10
3秒前
LMM完成签到,获得积分10
3秒前
3秒前
斯文凝蕊完成签到,获得积分10
4秒前
4秒前
飞飞飞发布了新的文献求助30
4秒前
疯狂的雨南完成签到,获得积分10
4秒前
科研通AI6.3的应助被qqq采纳,获得10
4秒前
俊逸的念蕾完成签到 ,获得积分10
4秒前
5秒前
alice完成签到,获得积分10
5秒前
5秒前
uiiii完成签到,获得积分10
5秒前
bjcyqz完成签到,获得积分10
5秒前
jery完成签到,获得积分10
5秒前
友好的人英完成签到,获得积分10
6秒前
科目三的应助被小陈采纳,获得10
6秒前
香草土拨鼠完成签到,获得积分20
6秒前
yang完成签到 ,获得积分10
6秒前
6秒前
我是谁的应助被珍珠采纳,获得30
7秒前
情怀的应助被歪比巴布采纳,获得10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180757
求助须知:如何正确求助?哪些是违规求助? 9570857
关于积分的说明 21814590
捐赠科研通 7777053
什么是DOI,文献DOI怎么找? 3433314
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479315